Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach

STAR Protoc. 2023 Sep 15;4(3):102440. doi: 10.1016/j.xpro.2023.102440. Epub 2023 Aug 9.

Abstract

Polypharmacology aids in the identification of multiple protein targets involved in disease pathology and selecting appropriate therapeutic compounds interacting with protein targets. Here, we present a protocol to identify the targets involved in obesity-linked diabetes and suitable phytocompounds to bind with the identified target. We describe steps to install and use softwares for identifying several protein targets by linking multiple diseases. This protocol allows the use of therapeutic compounds of both phytochemical and synthetic origins. For complete details on the use and execution of this protocol, please refer to Martiz et al.,1 and Maradesha et al.2.

Keywords: Bioinformatics; High Throughput Screening; Protein Biochemistry; Structural Biology.

MeSH terms

  • Hydrolases*
  • Polypharmacology*
  • Software

Substances

  • Hydrolases